LekoskopLekoskop
UK · ES · FR · CS · IT · NL · CH · HR · PL

Drug Safety Update — United Kingdom — May 2025

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 2 Oct 2026 08:50.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update1
clear

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

expand all dayscollapse all days

15 May 2025Thursday 15 May 2025

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Thiopurines and intrahepatic cholestasis of pregnancy
Intrahepatic cholestasis of pregnancy (ICP) has been rarely reported in patients treated with azathioprine products and is believed to be a risk applicable to all drugs in the thiopurine class (azathi…
What this means, batches, details

Loading…

Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

7 May 2025Wednesday 7 May 2025

open day ◀ ▶ 1 event · 1 important
Drug Safety Update Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor)
Psychological side effects such as anxiety, low mood, sleep disturbance, poor concentration, and forgetfulness have been infrequently reported in people with cystic fibrosis treated with Kaftrio. Heal…
What this means, batches, details

Loading…

Drug Safety Update on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

In total 2 events in this category.